Showing 951-960 of 5092 results for "".
Taltz Approved, Venus Versa Cleared, Sunbathing Linked to Longevity
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-taltz-approved-venus-versa-cleared-sunbathing-linked-to-longevity/18788/The IL-17 inhibitor Taltz (ixekizumab) from Eli Lilly is approved for adults with plaque psoriasis. Venus Concepts' Venus Versa is cleared for multiple aesthetic indications. Strata Sciences gets FDA clearance for new "Classifier Code" for use with MelaFind. Vitals.com shows that wait times are goinCutaneous Oncology
https://practicaldermatology.com/topics/skin-cancer-photoprotection/cutaneous-oncology/18638/Maui Derm Course Director George Martin, MD, recaps the discussion from the Cutaneous Oncology session during Maui Derm 2016. He shares his protocol for short-contact PDT therapy with an abbreviated incubation for reducing pain during treatment. Dr. Martin also offers an important clinical pearl forAuthority Tags - Protecting Your Content
https://practicaldermatology.com/topics/practice-management/authority-tags-protecting-your-content/18678/Practices need to maintain a strong online presence in order to build brand awareness. Google author tags is one strategy that is emerging as a robust marketing tool that supports building a strong online presence. What are author tags, how do they work, and how do they protect your content? The EkwPD Asks: The Future of Cosmetic Surgery
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/pd-asks-the-future-of-cosmetic-surgery/18680/PD Asks Joel Schlessinger, MD about the future of cosmetic dermatology. Watch Dr. Schlesinger discuss his views about how the speciality has evolved and grown with solid scientific research about treatments including fillers and toxins. He also discusses his meeting, Cosmetic Surgery Forum. Watch oOff-label Uses for Biologics
https://practicaldermatology.com/topics/psoriasis/off-label-uses-for-biologics/18964/Derm Insider Bonus Content: Host Neal Bhatia speaks with guests Alice Gottlieb, MD, Harold Farber, MD, and James Ulery, MD about various potential off-label uses for current and investigational systemic psoriasis therapies.Joel Schlessinger MD Explains How a Spa Helped Build His Practice
https://practicaldermatology.com/topics/practice-management/joel-schlessinger-md-explains-how-a-spa-helped-build-his-practice-/19156/As the dermatology and skin care industry expands, the opportunity to offer new procedures, techniques and products for your patients grows. One way that Joel Schlessinger MD chose to advance his business was by adding a spa on to his current practice. In this video, he explains how the decision helThe Biosimilar Revolution: A Look at the Potential Impact
https://practicaldermatology.com/issues/april-2025/the-biosimilar-revolution-a-look-at-the-potential-impact/35596/With many biosimilars expected to gain regulatory approval in coming months and years, Practical Dermatology interviewed Collin Blattner, DO, FAAD—an editorial board member and double-board–certified dermatologist who owns Clearchoice Dermatology, which has 12 locations in Oregon and Washington—abouDrs. Rosen and Bhatia Highlight Latest Drugs at Maui Derm
https://practicaldermatology.com/programs/practical-dermatology/drs-rosen-and-bhatia-highlight-latest-drugs-at-maui-derm/32914/The current landscape of therapeutics for dermatologic conditions is dramatic, with new groundbreaking drugs continuously becoming available.- Risk Stratification Testing for Melanomahttps://practicaldermatology.com/series/c-suite-chats/risk-stratification-testing-for-melanoma/32838/Derek Maetzold, president and CEO of Castle Biosciences, discusses the importance of personalized management and treatment approaches for patients diagnosed with melanoma, and how gene expression profile testing can help.
Cutaneous Oncology Update: Dr. Ruiz
https://practicaldermatology.com/programs/practical-dermatology/cutaneous-oncology-update-dr-ruiz/32696/Emily Ruiz, MD, discusses the key points she covered about nonmelanoma skin cancer during "Cutaneous Oncology Update 2025" at Maui Derm 2025, as well as her poster presentation on the 40-GEP test for head and neck cutaneous squamous cell carcinomas.